%0 Journal Article
%T First Nationwide Survey on the Resistance to First Line Anti-Tuberculosis Drugs in Ghana
%A Kennedy K. Addo
%A Richard Owusu
%A Christian Bonsu
%A Kwaku Owusu-Darko
%A Samuel O. Addo
%A Gloria I. Mensah
%A Mercy J. Newman
%A David Ofori-Adjei
%A Frank A. Bonsu
%J Journal of Tuberculosis Research
%P 68-80
%@ 2329-8448
%D 2018
%I Scientific Research Publishing
%R 10.4236/jtr.2018.61007
%X <strong>Background/objective:</strong> A nationwide survey on the resistance to first line anti-tuberculosis (anti-TB) drugs was conducted in Ghana from 2007-2008 by Noguchi Memorial Institute for Medical Research in collaboration with the National Tuberculosis Control Programme. We aimed to characterize mycobacterial species causing pulmonary tuberculosis (PTB) and determine the resistance pattern to first line anti-TB drugs among newly diagnosed and previously treated PTB patients in Ghana. <strong>Methods:</strong> Two sputum samples from consented new smear positive PTB patients who had never been treated for TB or had been on anti-TB treatment for less than a month and patients who had been treated for TB previously for more than a month in selected diagnostic centres nationwide were collected for culture, identification and drug susceptibility test. Culture positive isolates were tested against streptomycin (S), isoniazid (H), rifampicin (R) and ethambutol (E) using the simplified proportion method and line probe assay (LPA). The LPA was performed in mid-2017. <strong>Results:</strong> Among 410 samples, 345 positive cultures were obtained and identified as <em>Mycobacterium tuberculosis</em> complex (MTBC). Of the 345 isolates, 133 were further differentiated by GenoType MTBC<span style=\"font-size:6.5pt;font-family:&quot;\"><sup>&amp;reg;</sup></span> as <em>M. tuberculosis</em>, 126 (94.7%) and <em>M. africanum</em> 7 (5.3%). The overall drug resistance patterns were as follows: 43/345 (12.5%), 6/345 (1.7%), 9/345 (2.6%) and 71/345 (20.6%) were resistant to H, R, E and S respectively and 5/345 (1.4%) were multi-drug resistant (MDR). <strong>Conclusion:</strong> The results indicate high levels of resistance to S and H among new and previously treated TB patients. We recommend adequate surveillance systems including periodic national anti-TB drug resistance surveys.
%K Tuberculosis
%K National Survey
%K Drug Resistance
%K Ghana
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=83202